Fennec Pharmaceuticals announced it has completed its rolling submission of a New Drug Application (NDA) to theĀ U.S. Food and Drug Administration (FDA) for Pedmark (a unique formulation of sodium thiosulfate) for intravenous use and submitted a Marketing Authorization...